Abstract
Background
Manganese encephalopathy is a potential complication of parenteral nutrition. Lack of early recognition leads to unnecessary testing and to continued exposure to manganese.
Methods
Case report and review of the literature.
Results
We describe the clinical and imaging findings of a patient with manganese encephalopathy in whom the diagnosis was delayed due to lack of recognition of the characteristic imaging findings.
Conclusion
Manganese encephalopathy has protean clinical and imaging findings that can easily be overlooked.
References
Hardy G. Manganese in parenteral nutrition. Who, when, and why should we supplement? Gastroenterol. 2009;137:S29–35.
Dickerson RN. Manganese intoxication and parenteral nutrition. Nutrition. 2001;17:689–93.
Reimund JM, Dieiemann JL, Warter JM, et al. Factors associated to hypermanganesemia in patients receiving home parenteral nutrition. Clin Nutr. 2000;19:343–8.
Alves G, Thiebot J, Tracqui A, et al. Neurologic disorders due to brain manganese deposition in a jaundiced patient receiving long-term parenteral nutrition. J Parenter Enteral Nutr. 1997;21:41–5.
Santamaria AB. Manganese exposure, essentiality and toxicity. Indian J Med Res. 2008;128:484–500.
Kafritsa Y, Fell J, Long S, et al. Long term outcome of brain manganese deposition in patients on home parenteral nutrition. Arch Dis Child. 1998;79:263–5.
Cossgrove J, Zheng W. Manganese toxicity upon over exposure. NMR Biomed. 2004;17:544–53.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chalela, J.A., Bonillha, L., Neyens, R. et al. Manganese Encephalopathy: An Under-Recognized Condition in the Intensive Care Unit. Neurocrit Care 14, 456–458 (2011). https://doi.org/10.1007/s12028-010-9476-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-010-9476-5